Kelso Pharma acquires UK pharma business, ALTURiX
Released: Wednesday 19th February 2025
Kelso Pharma, the growing specialty pharma business backed by Apposite Capital, the healthcare specialist private equity investor, today (19 February 2025) announces the acquisition of the UK pharma business, ALTURiX Holdings Limited (ALTURiX).
For full details please click here.